Notice Information
Notice Title
NP39726 Generic and Biosimilar Cancer Medicines
Notice Description
Supply of Generic and Biosimilar Cancer Medicines to NHS Scotland.
Lot Information
Bendamustine powder for solution for infusion vials
Supply of Lot 1 Bendamustine powder for solution for infusion vials to NHS Scotland. The Authority intends to award this Lot as a single supplier framework agreement. Full details of Goods and volumes can be found within the ITT documents.
Renewal: This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.
Capecitabine tabletsSupply of Capecitabine tablets to NHS Scotland. The Authority intends to award this Lot as a single supplier framework agreement. Full details of Goods and volumes can be found within the ITT documents.
Renewal: This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.
Cisplatin solution for infusion vialsSupply of Cisplatin solution for infusion vials to NHS Scotland. The Authority intends to award this Lot as a single supplier framework agreement. Full details of Goods and volumes can be found within the ITT documents.
Renewal: This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.
Cyclophosphamide powder for solution for injection vialsSupply of Cyclophosphamide powder for solution for injection vials to NHS Scotland. The Authority intends to award this Lot as a single supplier framework agreement. Full details of Goods and volumes can be found within the ITT documents.
Renewal: This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.
Cytarabine solution for injection vialsSupply of Cytarabine solution for injection vials to NHS Scotland. The Authority intends to award this Lot as a single supplier framework agreement. Full details of Goods and volumes can be found within the ITT documents.
Renewal: This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.
Dacarbazine powder for solution for injection/infusion vialsSupply of Dacarbazine powder for solution for injection/infusion vials to NHS Scotland. The Authority intends to award this Lot as a single supplier framework agreement. Full details of Goods and volumes can be found within the ITT documents.
Renewal: This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.
Disodium folinate solution for injection vialsSupply of Disodium folinate solution for injection vials to NHS Scotland. The Authority intends to award this Lot as a single supplier framework agreement. Full details of Goods and volumes can be found within the ITT documents.
Renewal: This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.
Docetaxel solution for infusion vialsSupply of Docetaxel solution for infusion vials to NHS Scotland. The Authority intends to award this Lot as a single supplier framework agreement. Full details of Goods and volumes can be found within the ITT documents.
Renewal: This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.
Fluorouracil 25mg/ml solution for injection/infusion vialsSupply of Fluorouracil 25mg/ml solution for injection/infusion vials to NHS Scotland. The Authority intends to award this Lot as a single supplier framework agreement. Full details of Goods and volumes can be found within the ITT documents.
Renewal: This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.
Fluorouracil 50mg/ml solution for injection/infusion vialsSupply of Fluorouracil 50mg/ml solution for injection/infusion vials to NHS Scotland. The Authority intends to award this Lot as a single supplier framework agreement. Full details of Goods and volumes can be found within the ITT documents.
Renewal: This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.
Gemcitabine 38mg/ml solution for infusion vialsSupply of Gemcitabine 38mg/ml solution for infusion vials to NHS Scotland. The Authority intends to award this Lot as a single supplier. Full details of Goods and volumes can be found within the ITT documents.
Renewal: This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.
Gemcitabine 100mg/ml solution for infusion vialsSupply of Gemcitabine 100mg/ml solution for infusion vials to NHS Scotland. The Authority intends to award this Lot as a single supplier framework agreement. Full details of Goods and volumes can be found within the ITT documents.
Renewal: This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.
Ifosfamide powder for solution for injection vialsSupply of Ifosfamide powder for solution for injection vials to NHS Scotland. The Authority intends to award this Lot as a single supplier framework agreement. Full details of Goods and volumes can be found within the ITT documents.
Renewal: This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.
Methotrexate solution for injection/infusion vialsSupply of Methotrexate solution for injection/infusion vials to NHS Scotland. The Authority intends to award this Lot as a single supplier framework agreement. Full details of Goods and volumes can be found within the ITT documents.
Renewal: This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.
Oxaliplatin solution for infusion vialsSupply of Oxaliplatin solution for infusion vials to NHS Scotland. The Authority intends to award this Lot as a single supplier framework agreement. Full details of Goods and volumes can be found within the ITT documents.
Renewal: This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.
Paclitaxel solution for infusion vialsSupply of Paclitaxel solution for infusion vials to NHS Scotland. The Authority intends to award this Lot as a single supplier framework agreement. Full details of Goods and volumes can be found within the ITT documents.
Renewal: This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.
Temozolomide capsulesSupply of Temozolomide capsules to NHS Scotland. The Authority intends to award this Lot as a single supplier framework agreement. Full details of Goods and volumes can be found within the ITT documents.
Renewal: This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.
Vincristine solution for injection vialsSupply of Vincristine solution for injection vials to NHS Scotland. The Authority intends to award this Lot as a ranked multi-supplier framework agreement to a maximum of three (3) Framework Participants. Full details of Goods and volumes can be found within the ITT documents.
Renewal: This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.
Vinorelbine solution for infusion vialsSupply of Vinorelbine solution for infusion vials to NHS Scotland. The Authority intends to award this Lot as a single supplier framework agreement. Full details of Goods and volumes can be found within the ITT documents.
Renewal: This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.
Aprepitant capsulesSupply of Aprepitant capsules to NHS Scotland. The Authority intends to award this Lot as a single supplier framework agreement. Full details of Goods and volumes can be found within the ITT documents.
Renewal: This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.
Octreotide solution for injection ampoulesSupply of Octreotide solution for injection ampoules to NHS Scotland. The Authority intends to award this Lot as a single supplier framework agreement. Full details of Goods and volumes can be found within the ITT documents.
Renewal: This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.
Filgrastim solution for injection pre-filled syringesSupply of Filgrastim solution for injection pre-filled syringes to NHS Scotland. The Authority intends to award this Lot as a single supplier framework agreement. Full details of Goods and volumes can be found within the ITT documents.
Renewal: This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.
Pemetrexed powder for solution for infusion vialsSupply of Pemetrexed powder for solution for infusion vials to NHS Scotland. The Authority intends to award this Lot as a single supplier framework agreement. Full details of Goods and volumes can be found within the ITT documents.
Renewal: This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.
Pemetrexed solution for infusion vialsSupply of Pemetrexed solution for infusion vials to NHS Scotland. The Authority intends to award this Lot as a single supplier framework agreement. Full details of Goods and volumes can be found within the ITT documents.
Renewal: This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.
Dasatinib tabletsSupply of Dasatinib tablets to NHS Scotland. The Authority intends to award this Lot as a ranked multi-supplier framework agreement to a maximum of three (3) Framework Participants. Full details of Goods and volumes can be found within the ITT documents.
Renewal: This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.
Azacitidine, bevacizumab, doxorubicin pegylated liposomal, lanreotide, octreotide, rituximab and trastuzumab linesSupply of Azacitidine, bevacizumab, doxorubicin pegylated liposomal, lanreotide, octreotide, rituximab and trastuzumab lines to NHS Scotland. The Authority intends to award this Lot as a unranked multi-supplier framework agreement to a maximum of six (6) Framework Participants. Full details of Goods and volumes can be found within the ITT documents.
Renewal: This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.
Lenalidomide capsulesSupply of Lenalidomide capsules to NHS Scotland. The Authority intends to award this Lot as a ranked multi-supplier framework agreement to a maximum of three (3) Framework Participants. Full details of Goods and volumes can be found within the ITT documents.
Renewal: This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.
Pomalidomide capsulesSupply of Pomalidomide capsules to NHS Scotland. The Authority intends to award this Lot as a ranked multi-supplier framework agreement to a maximum of three (3) Framework Participants. Full details of Goods and volumes can be found within the ITT documents.
Renewal: This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire
Thalidomide capsulesSupply of Thalidomide capsules to NHS Scotland. The Authority intends to award this Lot as a ranked multi-supplier framework agreement to a maximum of three (3) Framework Participants. Full details of Goods and volumes can be found within the ITT documents.
Renewal: This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.
Irinotecan solution for infusion vialsSupply of Irinotecan solution for infusion vials to NHS Scotland. The Authority intends to award this Lot as a single supplier framework agreement. Full details of Goods and volumes can be found within the ITT documents.
Renewal: This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.
Etoposide solution for infusion vialsSupply of Etoposide solution for infusion vials to NHS Scotland. The Authority intends to award this Lot as a single supplier framework agreement. Full details of Goods and volumes can be found within the ITT documents.
Renewal: This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.
Doxorubicin solution for injection vialsSupply of Doxorubicin solution for injection vials to NHS Scotland. The Authority intends to award this Lot as a single supplier framework agreement. Full details of Goods and volumes can be found within the ITT documents.
Renewal: This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.
Carboplatin solution for infusion vialsSupply of Carboplatin solution for infusion vials to NHS Scotland. The Authority intends to award this Lot as a ranked multi-supplier framework agreement to a maximum of three (3) Framework Participants. Full details of Goods and volumes can be found within the ITT documents.
Renewal: This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.
Lenvatinib capsulesSupply of Lenvatinib capsules to NHS Scotland. The Authority intends to award this Lot as a ranked multi-supplier framework agreement to a maximum of three (3) Framework Participants. Full details of Goods and volumes can be found within the ITT documents.
Renewal: This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.
Range of ranked cancer medicine linesSupply of a range of ranked cancer medicine lines to NHS Scotland. The Authority intends to award this Lot as a ranked multi-supplier framework agreement to a maximum of three (3) Framework Participants. Full details of Goods and volumes can be found within the ITT documents.
Renewal: This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.
Range of single-supplier cancer medicine linesSupply of a range of single-supplier cancer medicine lines to NHS Scotland. The Authority intends to award this Lot as a single supplier framework agreement per product line. Full details of Goods and volumes can be found within the ITT documents.
Renewal: This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.
Notice Details
Publication & Lifecycle
- Open Contracting ID
- ocds-h6vhtk-06d3b5
- Publication Source
- Find A Tender Service
- Latest Notice
- https://www.find-tender.service.gov.uk/Notice/072326-2026
- Current Stage
- Tender
- All Stages
- Tender
Procurement Classification
- Notice Type
- Tender Notice
- Procurement Type
- Framework
- Procurement Category
- Goods
- Procurement Method
- Open
- Procurement Method Details
- Open procedure
- Tender Suitability
- Not specified
- Awardee Scale
- Not specified
Common Procurement Vocabulary (CPV)
- CPV Divisions
33 - Medical equipments, pharmaceuticals and personal care products
-
- CPV Codes
33600000 - Pharmaceutical products
Notice Value(s)
- Tender Value
- £197,026,942 £100M-£1B
- Lots Value
- £152,264,804 £100M-£1B
- Awards Value
- Not specified
- Contracts Value
- Not specified
Notice Dates
- Publication Date
- 30 Jul 20266 days ago
- Submission Deadline
- 26 Aug 20263 weeks to go
- Future Notice Date
- Not specified
- Award Date
- Not specified
- Contract Period
- 1 Feb 2027 - 31 Jan 2029 2-3 years
- Recurrence
- Not specified
Notice Status
- Tender Status
- Active
- Lots Status
- Active
- Awards Status
- Not Specified
- Contracts Status
- Not Specified
Buyer & Supplier
Contracting Authority (Buyer)
- Main Buyer
- THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS PUBLIC SERVICES DELIVERY SCOTLAND) (PSD SCOTLAND)
- Contact Name
- Available with D3 Tenders Premium →
- Contact Email
- Available with D3 Tenders Premium →
- Contact Phone
- Available with D3 Tenders Premium →
Buyer Location
- Locality
- EDINBURGH
- Postcode
- EH12 9EB
- Post Town
- Edinburgh
- Country
- Scotland
-
- Major Region (ITL 1)
- TLM Scotland
- Basic Region (ITL 2)
- TLM1 East Central Scotland
- Small Region (ITL 3)
- TLM13 City of Edinburgh
- Delivery Location
- TLM Scotland
-
- Local Authority
- City of Edinburgh
- Electoral Ward
- Drum Brae/Gyle
- Westminster Constituency
- Edinburgh South West
Further Information
Notice URLs
Open Contracting Data Standard (OCDS)
The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.
{
"tag": [
"compiled"
],
"id": "ocds-h6vhtk-06d3b5-2026-07-30T15:49:26+01:00",
"date": "2026-07-30T15:49:26+01:00",
"ocid": "ocds-h6vhtk-06d3b5",
"description": "The estimated values referred to in Section II.1.5 and within all Lots covers the twenty four(24) month contract duration and the twenty (24) month extension period of the framework agreement. The buyer is using PCS-Tender to conduct this ITT exercise. The Project code is 32105. For more information see: http://www.publiccontractsscotland.gov.uk/info/InfoCentre.aspx?ID=2343 A sub-contract clause has been included in this contract. For more information see: http://www.publiccontractsscotland.gov.uk/info/InfoCentre.aspx?ID=2363 Community benefits are included in this requirement. For more information see: https://www.gov.scot/policies/public-sector-procurement/community-benefits-in-procurement/ A summary of the expected community benefits has been provided as follows: It is a mandatory requirement that potential framework participants agree to support the concept, provision, and ongoing development of community benefits provision in relation to this framework. Potential framework participants are required to agree to this mandatory requirement. They are also requested to provide a summary of the community benefits that have recently been delivered within Scotland, if at all, and what impact and outcomes these have achieved. Potential framework participants are required to summarise any proposed community benefits that will be developed and delivered as part of this framework if successful or, alternatively, potential framework participants confirm that they will engage with the NHS Scotland's Community Benefits Gateway (CBG). This gateway, developed through requests from suppliers seeking opportunities to support the delivery of community benefits within the contracting region, provides information on community benefit opportunities. The CBG is a free and easy to use online service that connects NHS Scotland suppliers with third sector community organisations within Scotland and will be used for tracking and reporting and is an approved compliant route to the realisation of community benefits. For further information please visit NHSS Community Benefit Gateway (https://www.nss.nhs.scot/procurement-and-logistics/sustainability/access-our-community-benefit-gateway/). (SC Ref:838357)",
"initiationType": "tender",
"tender": {
"id": "ocds-h6vhtk-06d3b5",
"legalBasis": {
"id": "32014L0024",
"scheme": "CELEX"
},
"title": "NP39726 Generic and Biosimilar Cancer Medicines",
"status": "active",
"classification": {
"scheme": "CPV",
"id": "33600000",
"description": "Pharmaceutical products"
},
"mainProcurementCategory": "goods",
"description": "Supply of Generic and Biosimilar Cancer Medicines to NHS Scotland.",
"value": {
"amount": 197026942,
"currency": "GBP"
},
"lots": [
{
"id": "1",
"title": "Bendamustine powder for solution for infusion vials",
"description": "Supply of Lot 1 Bendamustine powder for solution for infusion vials to NHS Scotland. The Authority intends to award this Lot as a single supplier framework agreement. Full details of Goods and volumes can be found within the ITT documents.",
"awardCriteria": {
"criteria": [
{
"name": "Logistics",
"type": "quality",
"description": "5"
},
{
"type": "price",
"description": "95"
}
]
},
"value": {
"amount": 169388,
"currency": "GBP"
},
"contractPeriod": {
"startDate": "2027-02-01T00:00:00Z",
"endDate": "2029-01-31T23:59:59Z"
},
"hasRenewal": true,
"renewal": {
"description": "This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire."
},
"submissionTerms": {
"variantPolicy": "notAllowed"
},
"hasOptions": false,
"status": "active"
},
{
"id": "2",
"title": "Capecitabine tablets",
"description": "Supply of Capecitabine tablets to NHS Scotland. The Authority intends to award this Lot as a single supplier framework agreement. Full details of Goods and volumes can be found within the ITT documents.",
"awardCriteria": {
"criteria": [
{
"name": "Logistics",
"type": "quality",
"description": "5"
},
{
"type": "price",
"description": "95"
}
]
},
"value": {
"amount": 590765,
"currency": "GBP"
},
"contractPeriod": {
"startDate": "2027-02-01T00:00:00Z",
"endDate": "2029-01-31T23:59:59Z"
},
"hasRenewal": true,
"renewal": {
"description": "This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire."
},
"submissionTerms": {
"variantPolicy": "notAllowed"
},
"hasOptions": false,
"status": "active"
},
{
"id": "4",
"title": "Cisplatin solution for infusion vials",
"description": "Supply of Cisplatin solution for infusion vials to NHS Scotland. The Authority intends to award this Lot as a single supplier framework agreement. Full details of Goods and volumes can be found within the ITT documents.",
"awardCriteria": {
"criteria": [
{
"name": "Logistics",
"type": "quality",
"description": "5"
},
{
"type": "price",
"description": "95"
}
]
},
"value": {
"amount": 1008289,
"currency": "GBP"
},
"contractPeriod": {
"startDate": "2027-02-01T00:00:00Z",
"endDate": "2029-01-31T23:59:59Z"
},
"hasRenewal": true,
"renewal": {
"description": "This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire."
},
"submissionTerms": {
"variantPolicy": "notAllowed"
},
"hasOptions": false,
"status": "active"
},
{
"id": "5",
"title": "Cyclophosphamide powder for solution for injection vials",
"description": "Supply of Cyclophosphamide powder for solution for injection vials to NHS Scotland. The Authority intends to award this Lot as a single supplier framework agreement. Full details of Goods and volumes can be found within the ITT documents.",
"awardCriteria": {
"criteria": [
{
"name": "Logistics",
"type": "quality",
"description": "5"
},
{
"type": "price",
"description": "95"
}
]
},
"value": {
"amount": 338258,
"currency": "GBP"
},
"contractPeriod": {
"startDate": "2027-02-01T00:00:00Z",
"endDate": "2029-01-31T23:59:59Z"
},
"hasRenewal": true,
"renewal": {
"description": "This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire."
},
"submissionTerms": {
"variantPolicy": "notAllowed"
},
"hasOptions": false,
"status": "active"
},
{
"id": "6",
"title": "Cytarabine solution for injection vials",
"description": "Supply of Cytarabine solution for injection vials to NHS Scotland. The Authority intends to award this Lot as a single supplier framework agreement. Full details of Goods and volumes can be found within the ITT documents.",
"awardCriteria": {
"criteria": [
{
"name": "Logistics",
"type": "quality",
"description": "5"
},
{
"type": "price",
"description": "95"
}
]
},
"value": {
"amount": 122307,
"currency": "GBP"
},
"contractPeriod": {
"startDate": "2027-02-01T00:00:00Z",
"endDate": "2029-01-31T23:59:59Z"
},
"hasRenewal": true,
"renewal": {
"description": "This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire."
},
"submissionTerms": {
"variantPolicy": "notAllowed"
},
"hasOptions": false,
"status": "active"
},
{
"id": "7",
"title": "Dacarbazine powder for solution for injection/infusion vials",
"description": "Supply of Dacarbazine powder for solution for injection/infusion vials to NHS Scotland. The Authority intends to award this Lot as a single supplier framework agreement. Full details of Goods and volumes can be found within the ITT documents.",
"awardCriteria": {
"criteria": [
{
"name": "Logistics",
"type": "quality",
"description": "5"
},
{
"type": "price",
"description": "95"
}
]
},
"value": {
"amount": 250217,
"currency": "GBP"
},
"contractPeriod": {
"startDate": "2027-02-01T00:00:00Z",
"endDate": "2029-01-31T23:59:59Z"
},
"hasRenewal": true,
"renewal": {
"description": "This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire."
},
"submissionTerms": {
"variantPolicy": "notAllowed"
},
"hasOptions": false,
"status": "active"
},
{
"id": "8",
"title": "Disodium folinate solution for injection vials",
"description": "Supply of Disodium folinate solution for injection vials to NHS Scotland. The Authority intends to award this Lot as a single supplier framework agreement. Full details of Goods and volumes can be found within the ITT documents.",
"awardCriteria": {
"criteria": [
{
"name": "Logistics",
"type": "quality",
"description": "5"
},
{
"type": "price",
"description": "95"
}
]
},
"value": {
"amount": 283496,
"currency": "GBP"
},
"contractPeriod": {
"startDate": "2027-02-01T00:00:00Z",
"endDate": "2029-01-31T23:59:59Z"
},
"hasRenewal": true,
"renewal": {
"description": "This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire."
},
"submissionTerms": {
"variantPolicy": "notAllowed"
},
"hasOptions": false,
"status": "active"
},
{
"id": "9",
"title": "Docetaxel solution for infusion vials",
"description": "Supply of Docetaxel solution for infusion vials to NHS Scotland. The Authority intends to award this Lot as a single supplier framework agreement. Full details of Goods and volumes can be found within the ITT documents.",
"awardCriteria": {
"criteria": [
{
"name": "Logistics",
"type": "quality",
"description": "5"
},
{
"type": "price",
"description": "95"
}
]
},
"value": {
"amount": 808420,
"currency": "GBP"
},
"contractPeriod": {
"startDate": "2027-02-01T00:00:00Z",
"endDate": "2029-01-31T23:59:59Z"
},
"hasRenewal": true,
"renewal": {
"description": "This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire."
},
"submissionTerms": {
"variantPolicy": "notAllowed"
},
"hasOptions": false,
"status": "active"
},
{
"id": "11",
"title": "Fluorouracil 25mg/ml solution for injection/infusion vials",
"description": "Supply of Fluorouracil 25mg/ml solution for injection/infusion vials to NHS Scotland. The Authority intends to award this Lot as a single supplier framework agreement. Full details of Goods and volumes can be found within the ITT documents.",
"awardCriteria": {
"criteria": [
{
"name": "Logistics",
"type": "quality",
"description": "5"
},
{
"type": "price",
"description": "95"
}
]
},
"value": {
"amount": 231402,
"currency": "GBP"
},
"contractPeriod": {
"startDate": "2027-02-01T00:00:00Z",
"endDate": "2029-01-31T23:59:59Z"
},
"hasRenewal": true,
"renewal": {
"description": "This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire."
},
"submissionTerms": {
"variantPolicy": "notAllowed"
},
"hasOptions": false,
"status": "active"
},
{
"id": "12",
"title": "Fluorouracil 50mg/ml solution for injection/infusion vials",
"description": "Supply of Fluorouracil 50mg/ml solution for injection/infusion vials to NHS Scotland. The Authority intends to award this Lot as a single supplier framework agreement. Full details of Goods and volumes can be found within the ITT documents.",
"awardCriteria": {
"criteria": [
{
"name": "Logistics",
"type": "quality",
"description": "5"
},
{
"type": "price",
"description": "95"
}
]
},
"value": {
"amount": 1432949,
"currency": "GBP"
},
"contractPeriod": {
"startDate": "2027-02-01T00:00:00Z",
"endDate": "2029-01-31T23:59:59Z"
},
"hasRenewal": true,
"renewal": {
"description": "This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire."
},
"submissionTerms": {
"variantPolicy": "notAllowed"
},
"hasOptions": false,
"status": "active"
},
{
"id": "13",
"title": "Gemcitabine 38mg/ml solution for infusion vials",
"description": "Supply of Gemcitabine 38mg/ml solution for infusion vials to NHS Scotland. The Authority intends to award this Lot as a single supplier. Full details of Goods and volumes can be found within the ITT documents.",
"awardCriteria": {
"criteria": [
{
"name": "Logistics",
"type": "quality",
"description": "5"
},
{
"type": "price",
"description": "95"
}
]
},
"value": {
"amount": 310860,
"currency": "GBP"
},
"contractPeriod": {
"startDate": "2027-02-01T00:00:00Z",
"endDate": "2029-01-31T23:59:59Z"
},
"hasRenewal": true,
"renewal": {
"description": "This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire."
},
"submissionTerms": {
"variantPolicy": "notAllowed"
},
"hasOptions": false,
"status": "active"
},
{
"id": "14",
"title": "Gemcitabine 100mg/ml solution for infusion vials",
"description": "Supply of Gemcitabine 100mg/ml solution for infusion vials to NHS Scotland. The Authority intends to award this Lot as a single supplier framework agreement. Full details of Goods and volumes can be found within the ITT documents.",
"awardCriteria": {
"criteria": [
{
"name": "Logistics",
"type": "quality",
"description": "5"
},
{
"type": "price",
"description": "95"
}
]
},
"value": {
"amount": 313655,
"currency": "GBP"
},
"contractPeriod": {
"startDate": "2027-02-01T00:00:00Z",
"endDate": "2029-01-31T23:59:59Z"
},
"hasRenewal": true,
"renewal": {
"description": "This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire."
},
"submissionTerms": {
"variantPolicy": "notAllowed"
},
"hasOptions": false,
"status": "active"
},
{
"id": "15",
"title": "Ifosfamide powder for solution for injection vials",
"description": "Supply of Ifosfamide powder for solution for injection vials to NHS Scotland. The Authority intends to award this Lot as a single supplier framework agreement. Full details of Goods and volumes can be found within the ITT documents.",
"awardCriteria": {
"criteria": [
{
"name": "Logistics",
"type": "quality",
"description": "5"
},
{
"type": "price",
"description": "95"
}
]
},
"value": {
"amount": 1759061,
"currency": "GBP"
},
"contractPeriod": {
"startDate": "2027-02-01T00:00:00Z",
"endDate": "2029-01-31T23:59:59Z"
},
"hasRenewal": true,
"renewal": {
"description": "This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire."
},
"submissionTerms": {
"variantPolicy": "notAllowed"
},
"hasOptions": false,
"status": "active"
},
{
"id": "17",
"title": "Methotrexate solution for injection/infusion vials",
"description": "Supply of Methotrexate solution for injection/infusion vials to NHS Scotland. The Authority intends to award this Lot as a single supplier framework agreement. Full details of Goods and volumes can be found within the ITT documents.",
"awardCriteria": {
"criteria": [
{
"name": "Logistics",
"type": "quality",
"description": "5"
},
{
"type": "price",
"description": "95"
}
]
},
"value": {
"amount": 490564,
"currency": "GBP"
},
"contractPeriod": {
"startDate": "2027-02-01T00:00:00Z",
"endDate": "2029-01-31T23:59:59Z"
},
"hasRenewal": true,
"renewal": {
"description": "This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire."
},
"submissionTerms": {
"variantPolicy": "notAllowed"
},
"hasOptions": false,
"status": "active"
},
{
"id": "18",
"title": "Oxaliplatin solution for infusion vials",
"description": "Supply of Oxaliplatin solution for infusion vials to NHS Scotland. The Authority intends to award this Lot as a single supplier framework agreement. Full details of Goods and volumes can be found within the ITT documents.",
"awardCriteria": {
"criteria": [
{
"name": "Logistics",
"type": "quality",
"description": "5"
},
{
"type": "price",
"description": "95"
}
]
},
"value": {
"amount": 349538,
"currency": "GBP"
},
"contractPeriod": {
"startDate": "2027-02-01T00:00:00Z",
"endDate": "2029-01-31T23:59:59Z"
},
"hasRenewal": true,
"renewal": {
"description": "This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire."
},
"submissionTerms": {
"variantPolicy": "notAllowed"
},
"hasOptions": false,
"status": "active"
},
{
"id": "19",
"title": "Paclitaxel solution for infusion vials",
"description": "Supply of Paclitaxel solution for infusion vials to NHS Scotland. The Authority intends to award this Lot as a single supplier framework agreement. Full details of Goods and volumes can be found within the ITT documents.",
"awardCriteria": {
"criteria": [
{
"name": "Logistics",
"type": "quality",
"description": "5"
},
{
"type": "price",
"description": "95"
}
]
},
"value": {
"amount": 2541766,
"currency": "GBP"
},
"contractPeriod": {
"startDate": "2027-02-01T00:00:00Z",
"endDate": "2029-01-31T23:59:59Z"
},
"hasRenewal": true,
"renewal": {
"description": "This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire."
},
"submissionTerms": {
"variantPolicy": "notAllowed"
},
"hasOptions": false,
"status": "active"
},
{
"id": "20",
"title": "Temozolomide capsules",
"description": "Supply of Temozolomide capsules to NHS Scotland. The Authority intends to award this Lot as a single supplier framework agreement. Full details of Goods and volumes can be found within the ITT documents.",
"awardCriteria": {
"criteria": [
{
"name": "Logistics",
"type": "quality",
"description": "5"
},
{
"type": "price",
"description": "95"
}
]
},
"value": {
"amount": 257799,
"currency": "GBP"
},
"contractPeriod": {
"startDate": "2027-02-01T00:00:00Z",
"endDate": "2029-01-31T23:59:59Z"
},
"hasRenewal": true,
"renewal": {
"description": "This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire."
},
"submissionTerms": {
"variantPolicy": "notAllowed"
},
"hasOptions": false,
"status": "active"
},
{
"id": "21",
"title": "Vincristine solution for injection vials",
"description": "Supply of Vincristine solution for injection vials to NHS Scotland. The Authority intends to award this Lot as a ranked multi-supplier framework agreement to a maximum of three (3) Framework Participants. Full details of Goods and volumes can be found within the ITT documents.",
"awardCriteria": {
"criteria": [
{
"name": "Logistics",
"type": "quality",
"description": "5"
},
{
"type": "price",
"description": "95"
}
]
},
"value": {
"amount": 91122,
"currency": "GBP"
},
"contractPeriod": {
"startDate": "2027-02-01T00:00:00Z",
"endDate": "2029-01-31T23:59:59Z"
},
"hasRenewal": true,
"renewal": {
"description": "This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire."
},
"submissionTerms": {
"variantPolicy": "notAllowed"
},
"hasOptions": false,
"status": "active"
},
{
"id": "22",
"title": "Vinorelbine solution for infusion vials",
"description": "Supply of Vinorelbine solution for infusion vials to NHS Scotland. The Authority intends to award this Lot as a single supplier framework agreement. Full details of Goods and volumes can be found within the ITT documents.",
"awardCriteria": {
"criteria": [
{
"name": "Logistics",
"type": "quality",
"description": "5"
},
{
"type": "price",
"description": "95"
}
]
},
"value": {
"amount": 24630,
"currency": "GBP"
},
"contractPeriod": {
"startDate": "2027-02-01T00:00:00Z",
"endDate": "2029-01-31T23:59:59Z"
},
"hasRenewal": true,
"renewal": {
"description": "This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire."
},
"submissionTerms": {
"variantPolicy": "notAllowed"
},
"hasOptions": false,
"status": "active"
},
{
"id": "23",
"title": "Aprepitant capsules",
"description": "Supply of Aprepitant capsules to NHS Scotland. The Authority intends to award this Lot as a single supplier framework agreement. Full details of Goods and volumes can be found within the ITT documents.",
"awardCriteria": {
"criteria": [
{
"name": "Logistics",
"type": "quality",
"description": "5"
},
{
"type": "price",
"description": "95"
}
]
},
"value": {
"amount": 873964,
"currency": "GBP"
},
"contractPeriod": {
"startDate": "2027-02-01T00:00:00Z",
"endDate": "2029-01-31T23:59:59Z"
},
"hasRenewal": true,
"renewal": {
"description": "This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire."
},
"submissionTerms": {
"variantPolicy": "notAllowed"
},
"hasOptions": false,
"status": "active"
},
{
"id": "24",
"title": "Octreotide solution for injection ampoules",
"description": "Supply of Octreotide solution for injection ampoules to NHS Scotland. The Authority intends to award this Lot as a single supplier framework agreement. Full details of Goods and volumes can be found within the ITT documents.",
"awardCriteria": {
"criteria": [
{
"name": "Logistics",
"type": "quality",
"description": "5"
},
{
"type": "price",
"description": "95"
}
]
},
"value": {
"amount": 897199,
"currency": "GBP"
},
"contractPeriod": {
"startDate": "2027-02-01T00:00:00Z",
"endDate": "2029-01-31T23:59:59Z"
},
"hasRenewal": true,
"renewal": {
"description": "This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire."
},
"submissionTerms": {
"variantPolicy": "notAllowed"
},
"hasOptions": false,
"status": "active"
},
{
"id": "25",
"title": "Filgrastim solution for injection pre-filled syringes",
"description": "Supply of Filgrastim solution for injection pre-filled syringes to NHS Scotland. The Authority intends to award this Lot as a single supplier framework agreement. Full details of Goods and volumes can be found within the ITT documents.",
"awardCriteria": {
"criteria": [
{
"name": "Logistics",
"type": "quality",
"description": "5"
},
{
"type": "price",
"description": "95"
}
]
},
"value": {
"amount": 4796431,
"currency": "GBP"
},
"contractPeriod": {
"startDate": "2027-02-01T00:00:00Z",
"endDate": "2029-01-31T23:59:59Z"
},
"hasRenewal": true,
"renewal": {
"description": "This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire."
},
"submissionTerms": {
"variantPolicy": "notAllowed"
},
"hasOptions": false,
"status": "active"
},
{
"id": "26",
"title": "Pemetrexed powder for solution for infusion vials",
"description": "Supply of Pemetrexed powder for solution for infusion vials to NHS Scotland. The Authority intends to award this Lot as a single supplier framework agreement. Full details of Goods and volumes can be found within the ITT documents.",
"awardCriteria": {
"criteria": [
{
"name": "Logistics",
"type": "quality",
"description": "5"
},
{
"type": "price",
"description": "95"
}
]
},
"value": {
"amount": 14436,
"currency": "GBP"
},
"contractPeriod": {
"startDate": "2027-02-01T00:00:00Z",
"endDate": "2029-01-31T23:59:59Z"
},
"hasRenewal": true,
"renewal": {
"description": "This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire."
},
"submissionTerms": {
"variantPolicy": "notAllowed"
},
"hasOptions": false,
"status": "active"
},
{
"id": "27",
"title": "Pemetrexed solution for infusion vials",
"description": "Supply of Pemetrexed solution for infusion vials to NHS Scotland. The Authority intends to award this Lot as a single supplier framework agreement. Full details of Goods and volumes can be found within the ITT documents.",
"awardCriteria": {
"criteria": [
{
"name": "Logistics",
"type": "quality",
"description": "5"
},
{
"type": "price",
"description": "95"
}
]
},
"value": {
"amount": 1347937,
"currency": "GBP"
},
"contractPeriod": {
"startDate": "2027-02-01T00:00:00Z",
"endDate": "2029-01-31T23:59:59Z"
},
"hasRenewal": true,
"renewal": {
"description": "This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire."
},
"submissionTerms": {
"variantPolicy": "notAllowed"
},
"hasOptions": false,
"status": "active"
},
{
"id": "29",
"title": "Dasatinib tablets",
"description": "Supply of Dasatinib tablets to NHS Scotland. The Authority intends to award this Lot as a ranked multi-supplier framework agreement to a maximum of three (3) Framework Participants. Full details of Goods and volumes can be found within the ITT documents.",
"awardCriteria": {
"criteria": [
{
"name": "Logistics",
"type": "quality",
"description": "5"
},
{
"type": "price",
"description": "95"
}
]
},
"value": {
"amount": 1038368,
"currency": "GBP"
},
"contractPeriod": {
"startDate": "2027-02-01T00:00:00Z",
"endDate": "2029-01-31T23:59:59Z"
},
"hasRenewal": true,
"renewal": {
"description": "This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire."
},
"submissionTerms": {
"variantPolicy": "notAllowed"
},
"hasOptions": false,
"status": "active"
},
{
"id": "30",
"title": "Azacitidine, bevacizumab, doxorubicin pegylated liposomal, lanreotide, octreotide, rituximab and trastuzumab lines",
"description": "Supply of Azacitidine, bevacizumab, doxorubicin pegylated liposomal, lanreotide, octreotide, rituximab and trastuzumab lines to NHS Scotland. The Authority intends to award this Lot as a unranked multi-supplier framework agreement to a maximum of six (6) Framework Participants. Full details of Goods and volumes can be found within the ITT documents.",
"awardCriteria": {
"criteria": [
{
"name": "Logistics",
"type": "quality",
"description": "5"
},
{
"type": "price",
"description": "95"
}
]
},
"value": {
"amount": 30972852,
"currency": "GBP"
},
"contractPeriod": {
"startDate": "2027-02-01T00:00:00Z",
"endDate": "2029-01-31T23:59:59Z"
},
"hasRenewal": true,
"renewal": {
"description": "This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire."
},
"submissionTerms": {
"variantPolicy": "notAllowed"
},
"hasOptions": false,
"status": "active"
},
{
"id": "31",
"title": "Lenalidomide capsules",
"description": "Supply of Lenalidomide capsules to NHS Scotland. The Authority intends to award this Lot as a ranked multi-supplier framework agreement to a maximum of three (3) Framework Participants. Full details of Goods and volumes can be found within the ITT documents.",
"awardCriteria": {
"criteria": [
{
"name": "Logistics",
"type": "quality",
"description": "5"
},
{
"name": "Pregnancy Prevention Programme (PPP)",
"type": "quality",
"description": "5"
},
{
"type": "price",
"description": "90"
}
]
},
"value": {
"amount": 912775,
"currency": "GBP"
},
"contractPeriod": {
"startDate": "2027-02-01T00:00:00Z",
"endDate": "2029-01-31T23:59:59Z"
},
"hasRenewal": true,
"renewal": {
"description": "This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire."
},
"submissionTerms": {
"variantPolicy": "notAllowed"
},
"hasOptions": false,
"status": "active"
},
{
"id": "32",
"title": "Pomalidomide capsules",
"description": "Supply of Pomalidomide capsules to NHS Scotland. The Authority intends to award this Lot as a ranked multi-supplier framework agreement to a maximum of three (3) Framework Participants. Full details of Goods and volumes can be found within the ITT documents.",
"awardCriteria": {
"criteria": [
{
"name": "Logistics",
"type": "quality",
"description": "5"
},
{
"name": "Pregnancy Prevention Programme (PPP)",
"type": "quality",
"description": "5"
},
{
"type": "price",
"description": "90"
}
]
},
"value": {
"amount": 4619961,
"currency": "GBP"
},
"contractPeriod": {
"startDate": "2027-02-01T00:00:00Z",
"endDate": "2029-01-31T23:59:59Z"
},
"hasRenewal": true,
"renewal": {
"description": "This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire"
},
"submissionTerms": {
"variantPolicy": "notAllowed"
},
"hasOptions": false,
"status": "active"
},
{
"id": "33",
"title": "Thalidomide capsules",
"description": "Supply of Thalidomide capsules to NHS Scotland. The Authority intends to award this Lot as a ranked multi-supplier framework agreement to a maximum of three (3) Framework Participants. Full details of Goods and volumes can be found within the ITT documents.",
"awardCriteria": {
"criteria": [
{
"name": "Logistics",
"type": "quality",
"description": "5"
},
{
"name": "Pregnancy Prevention Programme (PPP)",
"type": "quality",
"description": "5"
},
{
"type": "price",
"description": "90"
}
]
},
"value": {
"amount": 428163,
"currency": "GBP"
},
"contractPeriod": {
"startDate": "2027-02-01T00:00:00Z",
"endDate": "2029-01-31T23:59:59Z"
},
"hasRenewal": true,
"renewal": {
"description": "This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire."
},
"submissionTerms": {
"variantPolicy": "notAllowed"
},
"hasOptions": false,
"status": "active"
},
{
"id": "16",
"title": "Irinotecan solution for infusion vials",
"description": "Supply of Irinotecan solution for infusion vials to NHS Scotland. The Authority intends to award this Lot as a single supplier framework agreement. Full details of Goods and volumes can be found within the ITT documents.",
"awardCriteria": {
"criteria": [
{
"name": "Logistics",
"type": "quality",
"description": "5"
},
{
"type": "price",
"description": "95"
}
]
},
"value": {
"amount": 751953,
"currency": "GBP"
},
"contractPeriod": {
"startDate": "2027-02-01T00:00:00Z",
"endDate": "2029-01-31T23:59:59Z"
},
"hasRenewal": true,
"renewal": {
"description": "This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire."
},
"submissionTerms": {
"variantPolicy": "notAllowed"
},
"hasOptions": false,
"status": "active"
},
{
"id": "28",
"title": "Etoposide solution for infusion vials",
"description": "Supply of Etoposide solution for infusion vials to NHS Scotland. The Authority intends to award this Lot as a single supplier framework agreement. Full details of Goods and volumes can be found within the ITT documents.",
"awardCriteria": {
"criteria": [
{
"name": "Logistics",
"type": "quality",
"description": "5"
},
{
"type": "price",
"description": "95"
}
]
},
"value": {
"amount": 984935,
"currency": "GBP"
},
"contractPeriod": {
"startDate": "2027-02-01T00:00:00Z",
"endDate": "2029-01-31T23:59:59Z"
},
"hasRenewal": true,
"renewal": {
"description": "This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire."
},
"submissionTerms": {
"variantPolicy": "notAllowed"
},
"hasOptions": false,
"status": "active"
},
{
"id": "10",
"title": "Doxorubicin solution for injection vials",
"description": "Supply of Doxorubicin solution for injection vials to NHS Scotland. The Authority intends to award this Lot as a single supplier framework agreement. Full details of Goods and volumes can be found within the ITT documents.",
"awardCriteria": {
"criteria": [
{
"name": "Logistics",
"type": "quality",
"description": "5"
},
{
"type": "price",
"description": "95"
}
]
},
"value": {
"amount": 277294,
"currency": "GBP"
},
"contractPeriod": {
"startDate": "2027-02-01T00:00:00Z",
"endDate": "2029-01-31T23:59:59Z"
},
"hasRenewal": true,
"renewal": {
"description": "This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire."
},
"submissionTerms": {
"variantPolicy": "notAllowed"
},
"hasOptions": false,
"status": "active"
},
{
"id": "3",
"title": "Carboplatin solution for infusion vials",
"description": "Supply of Carboplatin solution for infusion vials to NHS Scotland. The Authority intends to award this Lot as a ranked multi-supplier framework agreement to a maximum of three (3) Framework Participants. Full details of Goods and volumes can be found within the ITT documents.",
"awardCriteria": {
"criteria": [
{
"name": "Logistics",
"type": "quality",
"description": "5"
},
{
"type": "price",
"description": "95"
}
]
},
"value": {
"amount": 3480542,
"currency": "GBP"
},
"contractPeriod": {
"startDate": "2027-02-01T00:00:00Z",
"endDate": "2029-01-31T23:59:59Z"
},
"hasRenewal": true,
"renewal": {
"description": "This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire."
},
"submissionTerms": {
"variantPolicy": "notAllowed"
},
"hasOptions": false,
"status": "active"
},
{
"id": "34",
"title": "Lenvatinib capsules",
"description": "Supply of Lenvatinib capsules to NHS Scotland. The Authority intends to award this Lot as a ranked multi-supplier framework agreement to a maximum of three (3) Framework Participants. Full details of Goods and volumes can be found within the ITT documents.",
"awardCriteria": {
"criteria": [
{
"name": "Logistics",
"type": "quality",
"description": "5"
},
{
"type": "price",
"description": "95"
}
]
},
"value": {
"amount": 11600324,
"currency": "GBP"
},
"contractPeriod": {
"startDate": "2027-05-01T00:00:00+01:00",
"endDate": "2029-01-31T23:59:59Z"
},
"hasRenewal": true,
"renewal": {
"description": "This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire."
},
"submissionTerms": {
"variantPolicy": "notAllowed"
},
"hasOptions": false,
"status": "active"
},
{
"id": "35",
"title": "Range of ranked cancer medicine lines",
"description": "Supply of a range of ranked cancer medicine lines to NHS Scotland. The Authority intends to award this Lot as a ranked multi-supplier framework agreement to a maximum of three (3) Framework Participants. Full details of Goods and volumes can be found within the ITT documents.",
"awardCriteria": {
"criteria": [
{
"name": "Logistics",
"type": "quality",
"description": "5"
},
{
"type": "price",
"description": "95"
}
]
},
"value": {
"amount": 45208332,
"currency": "GBP"
},
"contractPeriod": {
"startDate": "2027-02-01T00:00:00Z",
"endDate": "2029-01-31T23:59:59Z"
},
"hasRenewal": true,
"renewal": {
"description": "This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire."
},
"submissionTerms": {
"variantPolicy": "notAllowed"
},
"hasOptions": false,
"status": "active"
},
{
"id": "36",
"title": "Range of single-supplier cancer medicine lines",
"description": "Supply of a range of single-supplier cancer medicine lines to NHS Scotland. The Authority intends to award this Lot as a single supplier framework agreement per product line. Full details of Goods and volumes can be found within the ITT documents.",
"awardCriteria": {
"criteria": [
{
"name": "Logistics",
"type": "quality",
"description": "5"
},
{
"type": "price",
"description": "95"
}
]
},
"value": {
"amount": 32684852,
"currency": "GBP"
},
"contractPeriod": {
"startDate": "2027-02-01T00:00:00Z",
"endDate": "2029-01-31T23:59:59Z"
},
"hasRenewal": true,
"renewal": {
"description": "This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire."
},
"submissionTerms": {
"variantPolicy": "notAllowed"
},
"hasOptions": false,
"status": "active"
}
],
"items": [
{
"id": "1",
"additionalClassifications": [
{
"scheme": "CPV",
"id": "33600000",
"description": "Pharmaceutical products"
}
],
"deliveryAddresses": [
{
"region": "UKM"
}
],
"deliveryLocation": {
"description": "All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014."
},
"relatedLot": "1"
},
{
"id": "2",
"additionalClassifications": [
{
"scheme": "CPV",
"id": "33600000",
"description": "Pharmaceutical products"
}
],
"deliveryAddresses": [
{
"region": "UKM"
}
],
"deliveryLocation": {
"description": "All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014."
},
"relatedLot": "2"
},
{
"id": "4",
"additionalClassifications": [
{
"scheme": "CPV",
"id": "33600000",
"description": "Pharmaceutical products"
}
],
"deliveryAddresses": [
{
"region": "UKM"
}
],
"deliveryLocation": {
"description": "All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014."
},
"relatedLot": "4"
},
{
"id": "5",
"additionalClassifications": [
{
"scheme": "CPV",
"id": "33600000",
"description": "Pharmaceutical products"
}
],
"deliveryAddresses": [
{
"region": "UKM"
}
],
"deliveryLocation": {
"description": "All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014."
},
"relatedLot": "5"
},
{
"id": "6",
"additionalClassifications": [
{
"scheme": "CPV",
"id": "33600000",
"description": "Pharmaceutical products"
}
],
"deliveryAddresses": [
{
"region": "UKM"
}
],
"deliveryLocation": {
"description": "All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014."
},
"relatedLot": "6"
},
{
"id": "7",
"additionalClassifications": [
{
"scheme": "CPV",
"id": "33600000",
"description": "Pharmaceutical products"
}
],
"deliveryAddresses": [
{
"region": "UKM"
}
],
"deliveryLocation": {
"description": "All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014."
},
"relatedLot": "7"
},
{
"id": "8",
"additionalClassifications": [
{
"scheme": "CPV",
"id": "33600000",
"description": "Pharmaceutical products"
}
],
"deliveryAddresses": [
{
"region": "UKM"
}
],
"deliveryLocation": {
"description": "All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014."
},
"relatedLot": "8"
},
{
"id": "9",
"additionalClassifications": [
{
"scheme": "CPV",
"id": "33600000",
"description": "Pharmaceutical products"
}
],
"deliveryAddresses": [
{
"region": "UKM"
}
],
"deliveryLocation": {
"description": "All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014."
},
"relatedLot": "9"
},
{
"id": "11",
"additionalClassifications": [
{
"scheme": "CPV",
"id": "33600000",
"description": "Pharmaceutical products"
}
],
"deliveryAddresses": [
{
"region": "UKM"
}
],
"deliveryLocation": {
"description": "All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014."
},
"relatedLot": "11"
},
{
"id": "12",
"additionalClassifications": [
{
"scheme": "CPV",
"id": "33600000",
"description": "Pharmaceutical products"
}
],
"deliveryAddresses": [
{
"region": "UKM"
}
],
"deliveryLocation": {
"description": "All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014."
},
"relatedLot": "12"
},
{
"id": "13",
"additionalClassifications": [
{
"scheme": "CPV",
"id": "33600000",
"description": "Pharmaceutical products"
}
],
"deliveryAddresses": [
{
"region": "UKM"
}
],
"deliveryLocation": {
"description": "All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014."
},
"relatedLot": "13"
},
{
"id": "14",
"additionalClassifications": [
{
"scheme": "CPV",
"id": "33600000",
"description": "Pharmaceutical products"
}
],
"deliveryAddresses": [
{
"region": "UKM"
}
],
"deliveryLocation": {
"description": "All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014."
},
"relatedLot": "14"
},
{
"id": "15",
"additionalClassifications": [
{
"scheme": "CPV",
"id": "33600000",
"description": "Pharmaceutical products"
}
],
"deliveryAddresses": [
{
"region": "UKM"
}
],
"deliveryLocation": {
"description": "All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014."
},
"relatedLot": "15"
},
{
"id": "17",
"additionalClassifications": [
{
"scheme": "CPV",
"id": "33600000",
"description": "Pharmaceutical products"
}
],
"deliveryAddresses": [
{
"region": "UKM"
}
],
"deliveryLocation": {
"description": "All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014."
},
"relatedLot": "17"
},
{
"id": "18",
"additionalClassifications": [
{
"scheme": "CPV",
"id": "33600000",
"description": "Pharmaceutical products"
}
],
"deliveryAddresses": [
{
"region": "UKM"
}
],
"deliveryLocation": {
"description": "All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014."
},
"relatedLot": "18"
},
{
"id": "19",
"additionalClassifications": [
{
"scheme": "CPV",
"id": "33600000",
"description": "Pharmaceutical products"
}
],
"deliveryAddresses": [
{
"region": "UKM"
}
],
"deliveryLocation": {
"description": "All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014."
},
"relatedLot": "19"
},
{
"id": "20",
"additionalClassifications": [
{
"scheme": "CPV",
"id": "33600000",
"description": "Pharmaceutical products"
}
],
"deliveryAddresses": [
{
"region": "UKM"
}
],
"deliveryLocation": {
"description": "All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014."
},
"relatedLot": "20"
},
{
"id": "21",
"additionalClassifications": [
{
"scheme": "CPV",
"id": "33600000",
"description": "Pharmaceutical products"
}
],
"deliveryAddresses": [
{
"region": "UKM"
}
],
"deliveryLocation": {
"description": "All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014."
},
"relatedLot": "21"
},
{
"id": "22",
"additionalClassifications": [
{
"scheme": "CPV",
"id": "33600000",
"description": "Pharmaceutical products"
}
],
"deliveryAddresses": [
{
"region": "UKM"
}
],
"deliveryLocation": {
"description": "All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014."
},
"relatedLot": "22"
},
{
"id": "23",
"additionalClassifications": [
{
"scheme": "CPV",
"id": "33600000",
"description": "Pharmaceutical products"
}
],
"deliveryAddresses": [
{
"region": "UKM"
}
],
"deliveryLocation": {
"description": "All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014."
},
"relatedLot": "23"
},
{
"id": "24",
"additionalClassifications": [
{
"scheme": "CPV",
"id": "33600000",
"description": "Pharmaceutical products"
}
],
"deliveryAddresses": [
{
"region": "UKM"
}
],
"deliveryLocation": {
"description": "All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014."
},
"relatedLot": "24"
},
{
"id": "25",
"additionalClassifications": [
{
"scheme": "CPV",
"id": "33600000",
"description": "Pharmaceutical products"
}
],
"deliveryAddresses": [
{
"region": "UKM"
}
],
"deliveryLocation": {
"description": "All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014."
},
"relatedLot": "25"
},
{
"id": "26",
"additionalClassifications": [
{
"scheme": "CPV",
"id": "33600000",
"description": "Pharmaceutical products"
}
],
"deliveryAddresses": [
{
"region": "UKM"
}
],
"deliveryLocation": {
"description": "All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014."
},
"relatedLot": "26"
},
{
"id": "27",
"additionalClassifications": [
{
"scheme": "CPV",
"id": "33600000",
"description": "Pharmaceutical products"
}
],
"deliveryAddresses": [
{
"region": "UKM"
}
],
"deliveryLocation": {
"description": "All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014."
},
"relatedLot": "27"
},
{
"id": "29",
"additionalClassifications": [
{
"scheme": "CPV",
"id": "33600000",
"description": "Pharmaceutical products"
}
],
"deliveryAddresses": [
{
"region": "UKM"
}
],
"deliveryLocation": {
"description": "All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014."
},
"relatedLot": "29"
},
{
"id": "30",
"additionalClassifications": [
{
"scheme": "CPV",
"id": "33600000",
"description": "Pharmaceutical products"
}
],
"deliveryAddresses": [
{
"region": "UKM"
}
],
"deliveryLocation": {
"description": "All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014."
},
"relatedLot": "30"
},
{
"id": "31",
"additionalClassifications": [
{
"scheme": "CPV",
"id": "33600000",
"description": "Pharmaceutical products"
}
],
"deliveryAddresses": [
{
"region": "UKM"
}
],
"deliveryLocation": {
"description": "All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014."
},
"relatedLot": "31"
},
{
"id": "32",
"additionalClassifications": [
{
"scheme": "CPV",
"id": "33600000",
"description": "Pharmaceutical products"
}
],
"deliveryAddresses": [
{
"region": "UKM"
}
],
"deliveryLocation": {
"description": "All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014."
},
"relatedLot": "32"
},
{
"id": "33",
"additionalClassifications": [
{
"scheme": "CPV",
"id": "33600000",
"description": "Pharmaceutical products"
}
],
"deliveryAddresses": [
{
"region": "UKM"
}
],
"deliveryLocation": {
"description": "All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014."
},
"relatedLot": "33"
},
{
"id": "16",
"additionalClassifications": [
{
"scheme": "CPV",
"id": "33600000",
"description": "Pharmaceutical products"
}
],
"deliveryAddresses": [
{
"region": "UKM"
}
],
"deliveryLocation": {
"description": "All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014."
},
"relatedLot": "16"
},
{
"id": "28",
"additionalClassifications": [
{
"scheme": "CPV",
"id": "33600000",
"description": "Pharmaceutical products"
}
],
"deliveryAddresses": [
{
"region": "UKM"
}
],
"deliveryLocation": {
"description": "All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014."
},
"relatedLot": "28"
},
{
"id": "10",
"additionalClassifications": [
{
"scheme": "CPV",
"id": "33600000",
"description": "Pharmaceutical products"
}
],
"deliveryAddresses": [
{
"region": "UKM"
}
],
"deliveryLocation": {
"description": "All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014"
},
"relatedLot": "10"
},
{
"id": "3",
"additionalClassifications": [
{
"scheme": "CPV",
"id": "33600000",
"description": "Pharmaceutical products"
}
],
"deliveryAddresses": [
{
"region": "UKM"
}
],
"deliveryLocation": {
"description": "All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014."
},
"relatedLot": "3"
},
{
"id": "34",
"additionalClassifications": [
{
"scheme": "CPV",
"id": "33600000",
"description": "Pharmaceutical products"
}
],
"deliveryAddresses": [
{
"region": "UKM"
}
],
"deliveryLocation": {
"description": "All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014."
},
"relatedLot": "34"
},
{
"id": "35",
"additionalClassifications": [
{
"scheme": "CPV",
"id": "33600000",
"description": "Pharmaceutical products"
}
],
"deliveryAddresses": [
{
"region": "UKM"
}
],
"deliveryLocation": {
"description": "All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014."
},
"relatedLot": "35"
},
{
"id": "36",
"additionalClassifications": [
{
"scheme": "CPV",
"id": "33600000",
"description": "Pharmaceutical products"
}
],
"deliveryAddresses": [
{
"region": "UKM"
}
],
"deliveryLocation": {
"description": "All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014."
},
"relatedLot": "36"
}
],
"submissionMethod": [
"electronicSubmission"
],
"submissionMethodDetails": "https://www.publictendersscotland.publiccontractsscotland.gov.uk/web/login.html",
"selectionCriteria": {
"criteria": [
{
"type": "suitability",
"description": "Economic operators may be excluded from this competition if they are in breach of any situation referred to in regulation 58 of the Public Contracts (Scotland) Regulations 2015",
"appliesTo": [
"supplier"
]
},
{
"type": "technical",
"description": "(a) Potential Framework Participants must be able to demonstrate the existence of a valid and current UK Marketing Authorisation (PL, PLGB, or PLPI number) that has been approved by the MHRA for all tendered Medicines by the start date of the Framework Agreement. (b) Potential Framework Participants and any sub-contractor(s) must possess valid certification of BS EN ISO 9001 or equivalent. (c) All tendered Goods must comply with the MHRA best Practice Guidance on Labelling and Packaging and the National Patient Safety Agency (\"NPSA\") Guidelines on Packaging and Labelling on pack design. (d) Potential Framework Participants are required to provide evidence that their organisation has taken steps to build their awareness of the climate change emergency and how they will respond.",
"minimum": "(a) Confirmation of existence of a valid and current UK Marketing Authorisation (PL, PLGB, PLPI number) that has been approved by the MHRA for all tendered Medicines by the start date of the Framework Agreement should be included in the Qualification Envelope of the ITT under the Technical and Professional ability: Quality Control. (b) Confirmation of the existence of valid certification of BS EN ISO 9001 or equivalent. Confirmation of such certification should be included in the Qualification Envelope of the ITT under the Quality Assurance Schemes. (c) Confirmation that samples for tendered Goods will be supplied upon request to ensure compliance with the MHRA best Practice Guidance on Labelling and Packaging and the National Patient Safety Agency (\"NPSA\") Guidelines on Packaging and Labelling on pack design. Confirmation of sample provision should be provided in the Qualification Envelope of the ITT under Technical and Professional ability: Products. (d) A completed copy of the Bidder Climate Change Plan Template, including planned projects and actions to reduce the bidder's carbon emissions should be provided in the Qualification Envelope of the ITT under Environmental Management Criteria. This does not need to contain calculated carbon emissions.",
"appliesTo": [
"supplier"
]
}
]
},
"procurementMethod": "open",
"procurementMethodDetails": "Open procedure",
"techniques": {
"hasFrameworkAgreement": true
},
"coveredBy": [
"GPA"
],
"tenderPeriod": {
"endDate": "2026-08-26T12:00:00+01:00"
},
"submissionTerms": {
"languages": [
"en"
],
"bidValidityPeriod": {
"durationInDays": 90
}
},
"awardPeriod": {
"startDate": "2026-08-26T12:00:00+01:00"
},
"bidOpening": {
"date": "2026-08-26T12:00:00+01:00"
},
"hasRecurrence": false,
"contractTerms": {
"hasElectronicOrdering": true,
"electronicInvoicingPolicy": "allowed",
"hasElectronicPayment": true
},
"reviewDetails": "The Authority will notify economic operators who submitted a tender or (where no deselection notification has previously been made) applied to be selected to tender, of its decision to award the framework agreement which notification will contain among other information, a summary of the reasons why the economic operators was unsuccessful. The notification will incorporate a 'standstill period' of a minimum of 10 clear calendar days (or a minimum of 15 if the communication method used is not electronic) between the date on which the Authority dispatches the notice(s) and the date on which the Authority proposes to conclude the relevant framework agreement. The bringing of court proceedings against the Authority during the standstill period will automatically continue the prohibition on entering into the framework agreement until the court proceedings are determined, discontinued, or disposed of, or the court, by interim order, brings to an end the prohibition. The remedies that may be awarded by the courts before the framework agreement has been entered into include the setting aside of the decision to award the framework agreement to the winning tenderer(s). The bringing of court proceedings against the Authority after the framework agreement has been entered into will not affect the framework agreement unless grounds for the imposition of special penalties under the Public Contracts (Scotland) Regulations 2015 can be established. Otherwise, the remedies that may be awarded by the courts where the framework agreement has been entered into are limited to the award of damages.",
"amendments": [
{
"id": "1",
"unstructuredChanges": [
{
"oldValue": {
"date": "2026-08-26T12:00:00+01:00"
},
"newValue": {
"date": "2026-09-01T12:00:00+01:00"
},
"where": {
"section": "IV.2.2",
"label": "Time limit"
}
},
{
"oldValue": {
"date": "2026-08-26T12:00:00+01:00"
},
"newValue": {
"date": "2026-09-01T12:00:00+01:00"
},
"where": {
"section": "IV.2.7",
"label": "Conditions for opening of tenders"
}
}
],
"description": "Delay to publishing ITT requiring extension to the ITT deadline to compensate."
}
]
},
"parties": [
{
"id": "GB-FTS-179412",
"name": "The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland)",
"identifier": {
"legalName": "The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland)"
},
"address": {
"streetAddress": "1 South Gyle Crescent.",
"locality": "Edinburgh",
"region": "UKM",
"postalCode": "EH12 9EB",
"countryName": "United Kingdom"
},
"contactPoint": {
"telephone": "+44 1312756000",
"email": "Cameron.Wright@nhs.scot",
"url": "https://www.publictendersscotland.publiccontractsscotland.gov.uk/web/login.html"
},
"roles": [
"buyer"
],
"details": {
"url": "http://publicservicesdelivery.scot/about/procurement/",
"buyerProfile": "https://www.publiccontractsscotland.gov.uk/search/Search_AuthProfile.aspx?ID=AA11883",
"classifications": [
{
"id": "BODY_PUBLIC",
"scheme": "TED_CA_TYPE",
"description": "Body governed by public law"
},
{
"id": "07",
"scheme": "COFOG",
"description": "Health"
}
]
}
},
{
"id": "GB-FTS-324",
"name": "Sheriff Court House",
"identifier": {
"legalName": "Sheriff Court House"
},
"address": {
"streetAddress": "27 Chambers Street",
"locality": "Edinburgh",
"postalCode": "EH1 1LB",
"countryName": "United Kingdom"
},
"contactPoint": {
"email": "edinburgh@scotcourts.gov.uk"
},
"roles": [
"reviewBody"
],
"details": {
"url": "https://scotcourts.gov.uk/the-courts/sheriff-court/about-sheriff-courts"
}
}
],
"buyer": {
"id": "GB-FTS-179412",
"name": "The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland)"
},
"links": [
{
"rel": "canonical",
"href": "https://api.publiccontractsscotland.gov.uk/v1/Notice?id=ocds-r6ebe6-0000838357"
},
{
"rel": "canonical",
"href": "https://api.publiccontractsscotland.gov.uk/v1/Notice?id=ocds-r6ebe6-0000838357"
}
],
"language": "en"
}